Clinical Research Directory
Browse clinical research sites, groups, and studies.
Role of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery
Sponsor: Patel Hospital, Pakistan
Summary
The goal of this clinical trial is to learn if tranexamic acid (TXA) helps reduce bleeding during bariatric surgery, such as laparoscopic sleeve gastrectomy (LSG) and mini gastric bypass (MGB). It will also look at how safe TXA is for people undergoing these procedures. The main questions it aims to answer are: Does TXA reduce the amount of blood loss during bariatric surgery? Are there any side effects or complications in patients who receive TXA? Researchers will compare TXA to standard care (no TXA) to see if it is effective in reducing bleeding. Participants will: Receive either TXA or no TXA (placebo) before surgery Undergo standard bariatric surgery (LSG or MGB) Have their blood loss, hemoglobin levels, and any complications monitored during and after surgery
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
140
Start Date
2023-06-12
Completion Date
2025-08-31
Last Updated
2025-08-01
Healthy Volunteers
No
Interventions
Tranexamic Acid
At the time of incision, 1000mg of the drug would be given intravenous, followed by two postoperative doses of 1000mg eight hours apart.
Normal Saline (Placebo)
At the time of incision, 10ml of the drug would be given intravenous, followed by two postoperative doses of 10ml eight hours apart.
Locations (1)
Patel Hospital
Karachi, Sindh, Pakistan